Laura Richert

9PUBLICATIONS
58CO-AUTHORS
Major global burdens of diseaseEconometric and statistical methodsNanotoxicology, health and safetyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 08, 2025
In danger: HIV vaccine research and development in Europe.

Roger Tatoud, Yves Lévy, Roger Le Grand

|Jul 16, 2024
Innate and Cellular Immune Response to the Ebola Vaccine Ad26.ZEBOV, MVA-BN-Filo: An Ancillary Study of the EBL2001 Phase 2 Trial.

Christine Lacabaratz, Mélany Durand, Aurélie Wiedemann

|May 31, 2024
Definition of Virological Endpoints Improving the Design of HIV Cure Strategies Using Analytical Antiretroviral Treatment Interruption.

Marie Alexandre, Mélanie Prague, Edouard Lhomme

|Mar 27, 2023
On the Choice of Longitudinal Models for the Analysis of Antitumor Efficacy in Mouse Clinical Trials of Patient-derived Xenograft Models.

Hélène Savel, Sandrine Barbier, Cécile Proust-Lima

|Jun 27, 2022
Engagement of TRAIL triggers degranulation and IFNγ production in human natural killer cells.

Johannes Höfle, Timo Trenkner, Nadja Kleist

|May 25, 2022
T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial.

Laura Richert, Jean-Daniel Lelièvre, Christine Lacabaratz

Pageof 2

Frequent Collaborators

6 joint publications

Rodolphe Thiébaut

4 joint publications

Christine Lacabaratz

3 joint publications

Yves Lévy

2 joint publications

Houreratou Barry